Patient Navigator Intervention for Vision Impairment or Blindness
(NYCES Trial)

Recruiting in Palo Alto (17 mi)

Overseen byLisa A. Hark

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Columbia University

Trial Summary

What is the purpose of this trial?Dr. Lisa A. Hark (PI and Study Chair) and an interdisciplinary team have designed the New York City Eye Study (NYCES) to promote eye and vision health by conducting eye health screenings in adults age 21+ (PAR-23-009/NOT-EY-22-004).

Eligibility Criteria

The NYC Eye Study is for adults aged 21+ living independently in certain affordable housing areas. It's aimed at those with eye conditions like blindness, cataract, diabetic retinopathy, and glaucoma. People with terminal illnesses or unable to consent due to dementia cannot participate.

Inclusion Criteria

I am 21 years old or older.

This criterion means that the participant must be living on their own in a housing area that is not too expensive.

Exclusion Criteria

I am unable to understand and give consent for treatment due to dementia.

You have a terminal illness and are expected to live less than 1 year.

Participant Groups

This study tests whether using patient navigators can improve eye health compared to usual care without them. Patient navigators are people who help guide patients through the healthcare system to ensure they receive appropriate care.

2Treatment groups

Active Control

Placebo Group

Group I: Arm 1: Intervention Using Patient NavigatorsActive Control1 Intervention

Consented participants referred to ophthalmology from the 9 developments randomized to the Intervention Arm will receive ongoing support from patient navigators to assist with all aspects of follow-up eye care at either Columbia Harkness Eye Institute or Harlem Hospital Ophthalmology, specifically eye exam appointment scheduling and arranging transportation over a 1-year period.

Group II: Arm 2: Usual Care + Automated Appointment RemindersPlacebo Group1 Intervention

Consented participants referred from the 5 developments randomized to the Usual Care Arm +Automated Appointment Reminders who are referred to an ophthalmologist for a follow-up eye exam will only be scheduled for their initial appointment at either Columbia Harkness Eye Institute or Harlem Hospital Ophthalmology. They will not receive enhanced support. Scheduling this initial appointment will allow tracking of adherence. Arm 2 represents a realistic choice available for participants following screening over a 1-year period.